Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT02829437
Recruiting Observational

Observational Study on Endometrial Stromal Tumors

NCT02829437 · tracked via the Priya Life Science Italy tracker
Sponsor
Italian Sarcoma Group
Phase
Observational
Started
2016-10
Last updated
2026-01-02

Condition(s) studied

Endometrial Stromal Tumors

Investigational drug(s) / intervention(s)

Treatment for EST

Treatment for EST: Surgery and/or Chemotherapy and or/radiotherapy for EST treatment according to disease guidelines: no specific treatment is imposed by protocol (observational study)

Study summary

Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * patients with a diagnosis of Endometrial Stromal Tumor (EST) according to the World Health Organization (WHO) classification 2003 or 2014 * Informed consent signature Exclusion Criteria: * patients with different diagnosis from EST

Primary outcome measure(s)

  • Disease natural history — Through survival, an average of 5 years
    Collection of data on the natural history of endometrial stromal tumors

Trial sites (13)

FacilityCityRegionStatus
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST Meldola FC Not Yet Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori Milan MI Recruiting
Istituto Europeo di Oncologia Milan MI Not Yet Recruiting
Azienda Ospedaliera Universitaria Paolo Giaccone Palermo PA Not Yet Recruiting
Centro di Riferimento Oncologico di Aviano Aviano PD Not Yet Recruiting
Istituto Oncologico Veneto Padova PD Not Yet Recruiting
Fondazione del Piemonte per l'Oncologia IRCC Candiolo Candiolo Torino Not Yet Recruiting
Policlinico S.Orsola Malpighi - Unit of Medical Oncology Bologna Italy Not Yet Recruiting
Azienda Ospedaliera Universitaria Careggi Florence Italy Not Yet Recruiting
Azienda Ospedaliero-Universitaria Careggi Florence Italy Not Yet Recruiting
Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4 Prato Italy Not Yet Recruiting
Campus Biomedico Roma Italy Not Yet Recruiting
Istituti Fisioterapici Ospitalieri di Roma Roma Italy Not Yet Recruiting

More Italian Sarcoma Group trials in Italy

Study on Clinical Features and Outcomes of Breast Sarcoma Recruiting
Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease Recruiting
Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS Recruiting
Observational Study on Skeletal Ewing's Sarcoma Recruiting
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02829437 on ClinicalTrials.gov ↗ ← All trials in Italy